Sandra has a Master’s in Pharmacy from the Korea University, Seoul, South Korea, with specialisation in nano drug delivery systems. She finished her one-year pre-registration pharmacy training in Indonesia, before joining the group in early 2018. Sandra will work on the development of biological nanoparticles for the targeted co-delivery of therapeutics in cancer treatment under the supervision of Dr Andrew Care and A/Prof Anwar Sunna.

​

publications: researchgate